Department of Thoracic Surgery, Amiens University Hospital, Amiens, France.
Department of Biostatistics, Clinical Research and Innovation Directorate, Amiens University Hospital, Amiens, France.
Interact Cardiovasc Thorac Surg. 2021 Jun 28;33(1):68-75. doi: 10.1093/icvts/ivab044.
The aim of this study was to assess the long-term outcomes of patients treated by anatomical pulmonary resection with the video-assisted thoracoscopic surgery (VATS) approach, VATS requiring intraoperative conversion to thoracotomy or an upfront open thoracotomy for lung cancer surgery.
We performed a retrospective single-centre study that included consecutive patients between January 2011 and December 2018 treated either by VATS (with or without intraoperative conversion) or open thoracotomy for non-small-cell lung cancer (NSCLC). Patients treated for a benign or metastatic condition, stage IV disease, multiple primary lung cancer or by resection, such as pneumonectomies or angioplastic/bronchoplastic/chest wall resections, were excluded.
Among 1431 patients, 846 were included: 439 who underwent full-VATS, 94 who underwent VATS-conversion (21 emergent, 73 non-emergent) and 313 treated with upfront open thoracotomy. The median follow-up was 37 months. There were no statistical differences in stage-specific overall survival between the full-VATS, VATS-conversion, and open thoracotomy groups, with 5-year OS for stage I NSCLC of 76%, 72.3% and 69.4%, respectively (P = 0.47). There was a difference in disease-free survival for stage I NSCLC, with 71%, 60.2% and 53%, respectively at 5 years (P = 0.013). Fewer complications occurred in the full-VATS group (pneumonia, arrhythmia, length of stay), but complication rates were similar between the VATS-conversion and thoracotomy groups.
VATS resection for NSCLC with intraoperative conversion does not appear to alter the long-term oncological outcome relative to full-VATS or open upfront thoracotomy. Postoperative complications were higher than for full-VATS and comparable to those for thoracotomy. VATS should be favoured when possible.
本研究旨在评估通过电视辅助胸腔镜手术(VATS)进行解剖性肺切除治疗的患者的长期结果,这些患者需要术中转为开胸手术或直接行开胸手术进行肺癌手术。
我们进行了一项回顾性单中心研究,纳入了 2011 年 1 月至 2018 年 12 月期间接受 VATS(包括术中转为 VATS 或开胸手术)或开胸手术治疗非小细胞肺癌(NSCLC)的连续患者。排除了因良性或转移性疾病、IV 期疾病、多原发肺癌或行肺切除术(如全肺切除术)、血管成形术/支气管成形术/胸廓切除术治疗的患者。
在 1431 名患者中,有 846 名患者符合纳入标准:439 名患者接受了完全 VATS 手术,94 名患者接受了 VATS 中转手术(21 例紧急,73 例非紧急),313 名患者接受了直接开胸手术。中位随访时间为 37 个月。在 I 期 NSCLC 患者中,全 VATS 组、VATS 中转组和开胸手术组之间在特定分期的总体生存率方面没有统计学差异,5 年 OS 率分别为 76%、72.3%和 69.4%(P=0.47)。在 I 期 NSCLC 患者中,无病生存率存在差异,5 年时分别为 71%、60.2%和 53%(P=0.013)。全 VATS 组的并发症发生率较低(肺炎、心律失常、住院时间),但 VATS 中转组和开胸手术组的并发症发生率相似。
对于 NSCLC,与完全 VATS 或直接开胸手术相比,术中转为 VATS 并不改变长期肿瘤学结果。术后并发症发生率高于完全 VATS,与开胸手术相当。应尽可能采用 VATS。